Vitamin D3, an up regulator of LL-37, has been hinted as helpful in addressing Parkinson’s in COVID-19 patients due to its super-promoter activity of Nrf2-KEAP, which promotes protective antioxidant and Ca2+ production and may work in conjunction with the potentially protective effect of LL-37 (146). This evidence concerns the gene CAMP and COVID-19.